Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Dynamics of the hazard for distant metastases after ipsilateral breast tumor recurrence according to estrogen receptor status: An analysis of 2851 patients.

Gennaro M, Di Cosimo S, Ardoino I, Veneroni S, Mariani L, Agresti R, Daidone MG, de Braud F, Apolone G, Biganzoli E, Demicheli R.

Breast. 2018 Aug;40:131-135. doi: 10.1016/j.breast.2018.05.004. Epub 2018 May 14.

PMID:
29772517
2.

Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient's Body Mass Index.

Desmedt C, Demicheli R, Fornili M, Bachir I, Duca M, Viglietti G, Berlière M, Piccart M, Sotiriou C, Sosnowski M, Forget P, Biganzoli E.

J Natl Cancer Inst. 2018 Oct 1;110(10):1115-1122. doi: 10.1093/jnci/djy042.

PMID:
29718396
3.

Recurrence dynamics of breast cancer according to baseline body mass index.

Biganzoli E, Desmedt C, Fornili M, de Azambuja E, Cornez N, Ries F, Closon-Dejardin MT, Kerger J, Focan C, Di Leo A, Nogaret JM, Sotiriou C, Piccart M, Demicheli R.

Eur J Cancer. 2017 Dec;87:10-20. doi: 10.1016/j.ejca.2017.10.007. Epub 2017 Oct 31.

PMID:
29096156
4.

Tumor dormancy and frailty models: A novel approach.

Rancoita PM, Valberg M, Demicheli R, Biganzoli E, Di Serio C.

Biometrics. 2017 Mar;73(1):260-270. doi: 10.1111/biom.12559. Epub 2016 Jul 11.

PMID:
27398936
5.

The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases.

Dillekås H, Demicheli R, Ardoino I, Jensen SAH, Biganzoli E, Straume O.

Breast Cancer Res Treat. 2016 Jul;158(1):169-178. doi: 10.1007/s10549-016-3857-1. Epub 2016 Jun 15.

6.

Cancer as a changed tissue's way of life (when to treat, when to watch and when to think).

Demicheli R, Quiton DF, Fornili M, Hrushesky WJ.

Future Oncol. 2016 Mar;12(5):647-57. doi: 10.2217/fon.15.336. Epub 2016 Feb 1. Review.

PMID:
26880385
7.

p53 status identifies triple-negative breast cancer patients who do not respond to adjuvant chemotherapy.

Coradini D, Biganzoli E, Ardoino I, Ambrogi F, Boracchi P, Demicheli R, Daidone MG, Moliterni A.

Breast. 2015 Jun;24(3):294-7. doi: 10.1016/j.breast.2015.01.007. Epub 2015 Feb 16.

PMID:
25698149
8.

Multimodal hazard rate for relapse in breast cancer: quality of data and calibration of computer simulation.

Retsky M, Demicheli R.

Cancers (Basel). 2014 Nov 27;6(4):2343-55. doi: 10.3390/cancers6042343.

9.
10.

Bimodal mortality dynamics for uveal melanoma: a cue for metastasis development traits?

Demicheli R, Fornili M, Biganzoli E.

BMC Cancer. 2014 Jun 2;14:392. doi: 10.1186/1471-2407-14-392.

11.

Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new findings and a review.

Retsky M, Demicheli R, Hrushesky WJ, Forget P, De Kock M, Gukas I, Rogers RA, Baum M, Sukhatme V, Vaidya JS.

Curr Med Chem. 2013;20(33):4163-76. Review.

12.

Is there a rationale for an anesthesiologist's role against cancer recurrence?

Forget P, Coulie PG, Retsky M, Demicheli R, Machiels JP, De Kock M.

Acta Anaesthesiol Belg. 2013;64(1):15-24. Review.

PMID:
23767173
13.

Tumours and tissues: similar homeostatic systems?

Demicheli R.

Target Oncol. 2013 Jun;8(2):97-105. doi: 10.1007/s11523-013-0277-6. Epub 2013 May 2. Review.

PMID:
23636780
14.

Metastasis dynamics for non-small-cell lung cancer: effect of patient and tumor-related factors.

Kelsey CR, Fornili M, Ambrogi F, Higgins K, Boyd JA, Biganzoli E, Demicheli R.

Clin Lung Cancer. 2013 Jul;14(4):425-32. doi: 10.1016/j.cllc.2013.01.002. Epub 2013 Mar 15.

PMID:
23499299
15.

Significance of ipsilateral breast tumor recurrence after breast conserving treatment: role of surgical removal.

Demicheli R, Ardoino I, Ambrogi F, Agresti R, Biganzoli E.

Chin J Cancer Res. 2013 Feb;25(1):22-31. doi: 10.3978/j.issn.1000-9604.2013.01.03.

16.

Promising development from translational or perhaps anti-translational research in breast cancer.

Retsky M, Demicheli R, Hrushesky WJ, Forget P, De Kock M, Gukas I, Rogers RA, Baum M, Pachmann K, Vaidya JS.

Clin Transl Med. 2012 Aug 28;1(1):17. doi: 10.1186/2001-1326-1-17.

17.

NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup.

Retsky M, Rogers R, Demicheli R, Hrushesky WJ, Gukas I, Vaidya JS, Baum M, Forget P, Dekock M, Pachmann K.

Breast Cancer Res Treat. 2012 Jul;134(2):881-8. doi: 10.1007/s10549-012-2094-5. Epub 2012 May 24.

PMID:
22622810
18.

Recurrence dynamics for non-small-cell lung cancer: effect of surgery on the development of metastases.

Demicheli R, Fornili M, Ambrogi F, Higgins K, Boyd JA, Biganzoli E, Kelsey CR.

J Thorac Oncol. 2012 Apr;7(4):723-30. doi: 10.1097/JTO.0b013e31824a9022.

19.

p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features.

Biganzoli E, Coradini D, Ambrogi F, Garibaldi JM, Lisboa P, Soria D, Green AR, Pedriali M, Piantelli M, Querzoli P, Demicheli R, Boracchi P, Nenci I, Ellis IO, Alberti S.

Jpn J Clin Oncol. 2011 Feb;41(2):172-9. doi: 10.1093/jjco/hyq227. Epub 2011 Jan 2.

PMID:
21199790
20.

Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast.

Demicheli R, Ardoino I, Boracchi P, Coradini D, Agresti R, Ferraris C, Gennaro M, Hrushesky WJ, Biganzoli E.

BMC Cancer. 2010 Nov 30;10:656. doi: 10.1186/1471-2407-10-656.

Supplemental Content

Loading ...
Support Center